BUTYCAPS
LIVE
Serial Number
79329022
Owner
ELIE HEALTH SOLUTIONS S.L.Attorney
John AlumitFiling Date
Nov 3, 2021
BUTYCAPS Trademark
Serial Number: 79329022 • Registration: 6966151
BUTYCAPS is a trademark filed by
ELIE HEALTH SOLUTIONS S.L.
on November 3, 2021. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
John Alumit ALUMIT IP
135 S. Jackson Street
Suite 200
Glendale
CA 91205
Trademark Details
Filing Date
November 3, 2021
Registration Date
January 31, 2023
Published for Opposition
November 15, 2022
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
May 30, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 5, 2023 FICS
FINAL DISPOSITION PROCESSED
May 5, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 30, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 31, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 31, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 15, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 15, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 26, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 11, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 11, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 11, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 11, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 11, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 6, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 6, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 6, 2022 TROA
REFUSAL PROCESSED BY IB
Oct 3, 2022 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 15, 2022 RFCS
REFUSAL PROCESSED BY MPU
Sep 14, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 21, 2022 RFCR
NON-FINAL ACTION WRITTEN
Aug 20, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 14, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 4, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 29, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 23, 2021 REPR